BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12215832)

  • 21. Value of static venous pressure for predicting arteriovenous graft thrombosis.
    Dember LM; Holmberg EF; Kaufman JS
    Kidney Int; 2002 May; 61(5):1899-904. PubMed ID: 11967043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of hemodialysis access in HIV-positive patients.
    Gorski TF; Gorski YC; Muney J
    Am Surg; 2002 Dec; 68(12):1104-6. PubMed ID: 12516818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary patency of thrombosed prosthetic vascular access grafts with aggressive surveillance, monitoring and endovascular management.
    Kakkos SK; Haddad GK; Haddad JA; Scully MM
    Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):356-65. PubMed ID: 18603454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular access monitoring improves outcomes.
    Sands JJ
    Blood Purif; 2005; 23(1):45-9. PubMed ID: 15627736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflow reduction by distalization of anastomosis treats efficiently high-inflow high-cardiac output vascular access for hemodialysis.
    Chemla ES; Morsy M; Anderson L; Whitemore A
    Semin Dial; 2007; 20(1):68-72. PubMed ID: 17244125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.
    Sajgure A; Choudhury A; Ahmed Z; Choudhury D
    Nephrol Dial Transplant; 2007 May; 22(5):1390-8. PubMed ID: 17267534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular access surveillance: evaluation of combining dynamic venous pressure and vascular access blood flow measurements.
    Hoeben H; Abu-Alfa AK; Reilly RF; Aruny JE; Bouman K; Perazella MA
    Am J Nephrol; 2003; 23(6):403-8. PubMed ID: 14566106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive methods to identify early vascular access dysfunction.
    Soule JL; Henry ML
    Semin Vasc Surg; 2007 Sep; 20(3):164-6. PubMed ID: 17884617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic venous access pressure ratio test for hemodialysis access monitoring.
    Frinak S; Zasuwa G; Dunfee T; Besarab A; Yee J
    Am J Kidney Dis; 2002 Oct; 40(4):760-8. PubMed ID: 12324911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study.
    Elseviers MM; Van Waeleghem JP;
    Nephrol News Issues; 2003 Jul; 17(8):61-4, 66-8, 99. PubMed ID: 12882114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.
    LeSar CJ; Merrick HW; Smith MR
    J Am Coll Surg; 1999 Jul; 189(1):73-9; discussion 79-81. PubMed ID: 10401743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CARI guidelines. Vascular access surveillance.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S1-11. PubMed ID: 18713118
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure.
    Wijnen E; Planken N; Keuter X; Kooman JP; Tordoir JH; de Haan MW; Leunissen KM; van der Sande F
    Nephrol Dial Transplant; 2006 Dec; 21(12):3514-9. PubMed ID: 16921189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of hemodynamic changes associated with two different polytetraflouroethylene arteriovenous fistulae in hemodialysis patients.
    Karakayali H; Yagmurdur MC; Tutar NU; Basaran O; Haberal M
    Transplant Proc; 2004 Nov; 36(9):2603-6. PubMed ID: 15621100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a vascular access surveillance program on service provision and access thrombosis.
    Jiang S; Stewart G; Barnes E; Jardine M; Razavian M; Gallagher M
    Semin Dial; 2013; 26(3):361-5. PubMed ID: 22994648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical bypass of symptomatic central venous obstruction for arteriovenous fistula salvage in hemodialysis patients.
    Suliman A; Greenberg JI; Angle N
    Ann Vasc Surg; 2008 Mar; 22(2):203-9. PubMed ID: 18346573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanical thrombectomy of occluded hemodialysis native fistulas and grafts using a hydrodynamic thrombectomy catheter: preliminary experience.
    Sahni V; Kaniyur S; Malhotra A; Fan S; Blakeney C; Fotheringham T; Sobeh M; Matson M
    Cardiovasc Intervent Radiol; 2005; 28(6):714-21. PubMed ID: 16059764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive measures of vascular access thrombosis: a prospective study.
    May RE; Himmelfarb J; Yenicesu M; Knights S; Ikizler TA; Schulman G; Hernanz-Schulman M; Shyr Y; Hakim RM
    Kidney Int; 1997 Dec; 52(6):1656-62. PubMed ID: 9407514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arteriovenous fistula for chronic hemodialysis in children.
    Kreidy R; Ghabril R
    J Med Liban; 2000; 48(5):288-93. PubMed ID: 12489584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.